Merck (MRK) on Tuesday announced an agreement under which funds managed by Blackstone (BX) Life Sciences will provide the New ...

Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 ...

Merck & Co. began Tuesday with back-to-back deals, revealing separate agreements to pay $150 million upfront for full control of an early-phase asset and pocket $700 million to support an expansive ...

Blackstone shares are now at the seventh day of an ongoing losing streak, accumulating total losses of -9.3% during this ...

Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 ...

Royalty Pharma has acquired a royalty stake in Alnylam’s Amvuttra, a drug that treats ATTR amyloidosis, from Blackstone for ...

Blackstone grows to $1.2T AUM with strong fee-based income and positioned for higher deal flow as rates ease. Learn why BX ...

Despite payout cut, Blackstone BDC “expects” a strong November, executive says. Even cutting the fund’s distributions – akin to dividends - won’t hamper the sales of Blackstone’s juggernaut business ...

Blackstone Life Sciences agreed to give Merck $700 million to support its development of an investigational cancer drug called sacituzumab tirumotecan in exchange for low-to-mid-single-digit royalties ...

Attempts to tie First Brands and Tricolor bankruptcies to private credit are fake news, says largest private investment firm.

Private equity giant Blackstone Inc. is partnering with Saudi Arabia’s new artificial intelligence company, Humain, to build ...

The value of expected initial public offerings for the firm’s portfolio companies over the next 12 months is among the ...